Sign In
Buy KDMN
$9.50
+0 (+0%)
At Close: Aug 17, 2022
New York, New York--(Newsfile Corp. - May 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Kad
Last Few Days for Shareholders to Actively Participate in Kadmon Holdings, Inc. (KDMN) Class Action - Bronstein, Gewirtz & Grossman, LLC
11:00am, Thursday, 27'th May 2021
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Compa
Kadmon to Present at Upcoming Investor Conferences
04:01pm, Tuesday, 25'th May 2021
NEW YORK, NY / ACCESSWIRE / May 25, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that Harlan W. Waksal, M.D.
New York, New York--(Newsfile Corp. - May 22, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN) and ce
New York, New York--(Newsfile Corp. - May 21, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between Octob
NEW YORK, May 19, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between October 1, 2020 and
Kadmon to Present Initial Safety Data from Phase 1 Study of KD033 at the 2021 American Society of Clinical Oncology Annual Meeting
05:00pm, Wednesday, 19'th May 2021
- Results Demonstrate KD033 was Well Tolerated in All Patients through Initial Dose Cohorts, Allowing for Continuation of Dose Escalation - NEW YORK, NY / ACCESSWIRE / May 19, 2021 / Kadmon Holdings,
NEW YORK, May 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN) and certain of its o
Kadmon: PDUFA Delay Not A Major Concern
12:21pm, Sunday, 16'th May 2021
Kadmon's May PDUFA has been delayed by 3 months to review new data. Lead asset Belumosudil has outstanding data in Chronic GVHD.
New York, New York--(Newsfile Corp. - May 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between Octo
NEW YORK, May 13, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN) and certain of its of
New York, New York--(Newsfile Corp. - May 12, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between Octo
NEW YORK, May 5, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between October 1, 2020 and M
New York, New York--(Newsfile Corp. - April 30, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between Oct
ROSEN, A LEADING LAW FIRM, Encourages Kadmon Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline – KDMN
08:15pm, Thursday, 29'th Apr 2021
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between October 1, 2020 and March 10, 20
